Farhad Zamani

ORCID: 0000-0001-7409-3412
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Liver Disease Diagnosis and Treatment
  • Hepatitis C virus research
  • Hepatitis B Virus Studies
  • Diet, Metabolism, and Disease
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • COVID-19 Clinical Research Studies
  • Pancreatic and Hepatic Oncology Research
  • Gastric Cancer Management and Outcomes
  • Nutritional Studies and Diet
  • Helicobacter pylori-related gastroenterology studies
  • Liver Disease and Transplantation
  • Obesity, Physical Activity, Diet
  • Pancreatitis Pathology and Treatment
  • SARS-CoV-2 and COVID-19 Research
  • Pediatric Hepatobiliary Diseases and Treatments
  • Gallbladder and Bile Duct Disorders
  • Alcohol Consumption and Health Effects
  • Health Promotion and Cardiovascular Prevention
  • Gastrointestinal disorders and treatments
  • Celiac Disease Research and Management
  • Colorectal Cancer Screening and Detection
  • Microscopic Colitis
  • Hepatitis Viruses Studies and Epidemiology
  • Colorectal Cancer Treatments and Studies
  • Birth, Development, and Health

Iran University of Medical Sciences
2016-2025

Jahrom University
2025

Jahrom University of Medical Sciences
2025

Firoozgar General Hospital
2014-2023

Tehran University of Medical Sciences
2004-2020

Columbus Oncology and Hematology Associates
2020

Children's Medical Center
2020

University of Florida
2020

Razi Vaccine and Serum Research Institute
2016

Zanjan University of Medical Sciences
2016

To evaluate the efficacy of empagliflozin compared to pioglitazone in patients with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes (T2DM). In this prospective randomized, double-blind, placebo-controlled trial, we assigned 106 NAFLD T2DM receive 10 mg (n = 35), 30 34), or placebo 37) for 24 weeks. Liver fat content stiffness were measured using fibroscans. Body composition assessment was performed by dual-energy x-ray absorptiometry (DEXA) scans. The primary end point change...

10.1007/s13300-021-01011-3 article EN cc-by-nc Diabetes Therapy 2021-02-14

Despite the high prevalence of non-alcoholic fatty liver disease (NAFLD) and its associated co-morbidities, no efficient treatment in a percentage individuals is available. Beneficial effects sodium–glucose co-transporter 2 inhibitors on have been investigated people with type diabetes (T2DM). The aim this study was to explore effect empagliflozin steatosis fibrosis patients NAFLD without T2DM. In prospective randomized, double-blind, placebo-controlled clinical trial, participants were...

10.1007/s12325-020-01498-5 article EN cc-by-nc Advances in Therapy 2020-09-25

To evaluate the effects of synbiotic supplementation on insulin resistance and lipid profile in individuals with metabolic syndrome, we conducted a randomised, double-blind, placebo-controlled pilot study thirty-eight subjects syndrome; they were supplemented either capsules containing 200 million seven strains friendly bacteria plus fructo-oligosaccharide or placebo twice day for 28 weeks. Both (G1) (G2) groups advised to follow an energy-balanced diet physical activity recommendations....

10.1017/s0007114514000919 article EN British Journal Of Nutrition 2014-05-22

AIM:To determine the discriminatory performance of fatty liver index (FLI) for non-alcoholic disease (NAFLD). METHODS:The data 5052 subjects aged over 18 years were analyzed.FLI was calculated from body mass index, waist circumference (WC), triglyceride, and gamma glutamyl transferase data.Logistic regression analysis conducted to

10.3748/wjg.v22.i10.3023 article EN cc-by-nc World Journal of Gastroenterology 2016-01-01

ABSTRACT Background Central obesity has been recognized as a main risk factor for cardiovascular ( CV ) events. Three popular central indices are waist circumference, waist‐to‐hip ratio WHR ), and waist‐to‐height ratio; abdominal volume index conicity 2 recent novel indices. The aim of this study is to determine the performance these best predict 10‐year Hypothesis Some can be used risk. Methods In total, 3199 subjects (age range, 40–79 years) were enrolled in cross‐sectional study. American...

10.1002/clc.22437 article EN Clinical Cardiology 2015-09-01

Background and Aims: Although several studies have suggested opium as a risk factor for cancers of the esophagus, stomach, larynx, lung, bladder, no previous study has examined association with pancreatic cancer. We aimed to between use cancer in Iran, using case-control design. also studied cigarette smoking alcohol consumption cancer, which little information was available from this population. Methods: Cases controls were selected patients who referred 4 endoscopic ultrasound centers...

10.1097/md.0000000000003922 article EN cc-by-nc Medicine 2016-07-01

Nonalcoholic fatty liver disease (NAFLD) is an emerging cause of chronic diseases and a major health problem worldwide. Dietary patterns may play critical role in controlling preventing this disease, but the available evidence scarce. The current study aims to ascertain association adherence Approach Stop Hypertension (DASH) diet Mediterranean (MeD) with nonalcoholic among Iranian adults Amol Cohort Study (AmolCS). In cross-sectional analysis 3220 (55.3% men), age ≥ 18 years (46.96 ± 14.67),...

10.1038/s41598-022-06035-8 article EN cc-by Scientific Reports 2022-02-08

Abstract Background Pancreatic cancer (PC) presents a significant challenge in oncology because of its late-stage diagnosis and limited treatment options. The inadequacy current screening methods has prompted investigations into stool-based assays microbial classifiers as potential early detection markers. gut microbiota composition PC patients may be influenced by population differences, thereby impacting the accuracy disease prediction. However, comprehensive profiling analysis these...

10.1186/s13099-025-00698-0 article EN cc-by Gut Pathogens 2025-04-16

BACKGROUND/AIMS Noninvasive markers for predicting significant fibrosis and inflammation have not yet been validated in an unselected group of chronic hepatitis B virus (HBV) carriers. The aim this study was to create noninvasive models predict HBV METHODS A total 276 (229 HBeAg negative, 47 positive) consecutive treatment naïve patients chronically infected with who attended our center over a 36-month period underwent liver biopsy. negative were randomly divided into two cohorts: training...

10.1111/j.1572-0241.2006.00788.x article EN The American Journal of Gastroenterology 2006-11-01

Background: A strong association between obesity and non-alcoholic fatty liver disease (NAFLD) has been reported. Objectives: This study was conducted to evaluate if new indices, including a body shape index (ABSI) roundness (BRI), have stronger associations with NAFLD than waist-to-hip ratio (WHR) waist-to-height (WHtR). Methods: In this cross-sectional study, we utilized the data of 4,872 participants aged 18 - 74 years from cohort among 6,143 subjects in northern Iran. Logistic regression...

10.5812/hepatmon.39575 article EN Hepatitis Monthly 2016-08-14
Coming Soon ...